Advanced search
Publication Cover
Pharmacogenomics Volume 7, 2006 - Issue 5
Submit an article Journal homepage
259
Views
0
CrossRef citations to date
0
Altmetric
Review

The Application of CD Antigen Proteomics to Pharmacogenomics

Adrian Woolfson1 University of Cambridge School of Clinical Medicine, Addenbrooke‘s Hospital, Hills Road, Box 11, CambridgeCB2 2SP, UK. Tel: +44 1223 328 466; Fax: +44 1223 336 709;[email protected]View further author information
,
Peter Ellmark2 Univerity of Sydney School of Molecular & Microbial Biosciences NSW 2006 Australia;3 Lund University Department of Immunotechnology, BMCD13 SE-221 84Lund, SwedenView further author information
,
Jeremy S Chrisp4 Medsaic Pty Ltd, Suite 145, National Innovation Centre, Australian Technology Park, Garden Street, Eveleigh, NSW1430, AustraliaView further author information
,
Mike A Scott5 University of Cambridge, Department of Haematology, Addenbrooke‘s Hospital, Hills Road, CambridgeCB2 2QQ, UKView further author information
&
Richard I Christopherson2 Univerity of Sydney School of Molecular & Microbial Biosciences NSW 2006 AustraliaView further author information
Pages 759-771 | Published online: 03 Aug 2006

Bibliography

  • Baudin B : Angiotensin I-converting enzyme (ACE) for sarcoidosis diagnosis.Pathol. Biol.53(3), 183–188 (2005).
  • Nustad K , BastRC Jr, O'Brien TJ et al.: Specificity and affinity of 26 monoclonal antibodies against the CA125-related antigen. Report from the ISOBM TD1 workshop. Tumor Biology17(4), 196–219 (1996).
  • Paez JG , JannePA, LeeJC: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.Science304(5676), 1497–1500 (2004).
  • Schoniger-Hekele M , MullerC: The combined elevation of tumor markers CA 9–9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis.Dig. Dis. Sci.51(2), 338–345 (2006).
  • Xu FJ , RamakrishnanS, DalyL et al.: Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. Am. J. Obstet. Gynecol.165, 1356–1362 (1991).
  • Zola H : Human leukocyte differentiation antigens as therapeutic targets: the CD molecules and CD antibodies.Expert Opin. Biol. Ther.1(3), 375–383 (2001).
  • Bleharski JR , LiH, MeinkenC et al.: Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science301(5639), 1527–1530 (2003).
  • Rosenwald A , WrightG, ChanWC et al.: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med.346(25), 1937–1947 (2002).
  • Van de Vijver MJ, he YD, van‘t Veer LJ et al.: A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med.347(25), 1999–2009 (2002).
  • Caldas C , AparicioSA: The molecular outlook.Nature415(6871), 484–485 (2002).
  • Garber K : Genomic medicine. Gene expression tests foretell breast cancer's future.Science303(5665), 54–55 (2004).
  • Gulmann C , SheehanKM, Kay EWet al.: Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer. J. Pathol.208(5), 595–606 (2006).
  • Yanagisawa K , ShyrY, XuBJ et al.: Proteomic patterns of tumour subsets in non-small cell lung cancer. Lancet362(9382), 433–439 (2003).
  • Banks R , Selby,P: Clinical proteomics – insights into pathologies and benefits for patients.Lancet362(9382), 415–416 (2003).
  • Kishimoto T , GovertS, KitutaniH et al.: CD antigens 1996. Blood89(10), 3502 (1997).
  • Mason D , AndreP, BensussanA et al.: CD antigens 2001: aims and results of HLDA Workshops. Stem Cells19(6), 556–562 (2001).
  • Zola H , SwartB, NicholsonI et al.: CD molecules 2005: human cell differentiation molecules. Blood106(9), 3123–3126 (2005).
  • Fischer K , ScotetE, NiemeyerM et al.: Phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl Acad. Sci. USA101(29), 685–690 (2004).
  • Ray N , DomsRW: HIV-1 coreceptors and their inhibitors.Curr. Top. Microbiol. Immunol.303, 97–120 (2006).
  • Wagner C , OchmannC, SchoelsM et al.: The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes. Mol. Immunol.43(6), 643–651 (2006).
  • Munroe ME , BishopGA: Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation.J. Biol. Chem.279(51), 53222–53231 (2004).
  • Lebedeva T , DustinML, SykulevY: ICAM-1 co-stimulates target cells to facilitate antigen presentation.Curr. Opin. Immunol.17(3), 251–258 (2005).
  • Chen EI , HewelJ, Felding-HabermannB: Large-scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT).Mol. Cell Proteomics5(1), 53–56 (2006).
  • Hoogland C , MostaguirK, SanchezJC et al.:. SWISS-2DPAGE, ten years later. Proteomics4(8), 2352–2356 (2004).
  • Carter P : Improving the efficacy of antibody-based cancer therapies.Nature Rev. Cancer1(2), 118–129 (2001).
  • Woolfson A , MilsteinC: Alternative splicing generates secretory isoforms of human CD1.Proc. Natl Acad. Sci. USA91(14), 6683–6687 (1994).
  • Milstein C : The impact of monoclonal antibodies on studies of the differentiation of lymphocytes. In:Leukocyte Typing. Bernard A, Boumsell L, Hill C (Eds), Springer-Verlag, New York, NY, USA (1984).
  • Belov L , de la Vega, dos Remedios CG et al.: Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res.61, 4483–4489 (2001).
  • Belov L , HuangP, BarberN et al.: Identification of repertoires of surface antigens on leukaemias using an antibody microarray. Proteomics3, 2147–2154 (2003).
  • Ellmark P , BelovL, HuangP et al.: Multiplex detection of surface molecules on colorectal cancers. Proteomics6, 1791–1802 (2006).
  • Belov L , MulliganSP, BarberN et al.: Classification of human leukemias and lymphomas using extensive immunophenotypes obtained by cell capture on an antibody microarray. Brit. J. Haem. Resubmitted after review (2006).
  • Woolfson A , StebbingJ, TomB et al.: Conservation of unique CD cell surface mosaics in HIV-infected individuals. Blood106, 1003–1007 (2005)
  • Liotta L , FerrariM, PetricoinE: Clinical proteomics: Written in blood.Nature425, 905 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.